Blueriver Acquisition CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
8-K: BlueRiver Acquisition Corp. Secures Shareholder Approval for Business Combination Deadline Extension
BlueRiver Acquisition Corp. shareholders overwhelmingly approved an amendment to extend the deadline for completing a business combination until August 2, 2026.
OTC.Pink
BlueRiver Acquisition Corp. successfully obtained shareholder approval to extend the deadline for completing a business combination by up to 12 months.
OTC.Pink
BlueRiver Acquisition Corp. has been delisted from the NYSE American after withdrawing its appeal, with trading of its shares and units suspended.
OTC.Pink
BlueRiver Acquisition Corp.'s merger agreement with Spinal Stabilization Technologies has been terminated, and the company's warrants are facing delisting from NYSE American.
OTC.Pink
BlueRiver Acquisition Corp. has amended its merger agreement to extend the closing date to March 31, 2024, while also facing potential delisting from the NYSE American.
OTC.Pink
BlueRiver Acquisition Corp. has increased the required deposit into its trust account for each unredeemed public share to $0.025 per month for a potential extension of its termination date.